Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
About this study
This is a prospective observational registry for patients with invasive lobular carcinoma (ILC) of the breast. After the first 1cohort is enrolled, the collected data will be utilized to develop an ILC specific response assessment tool.
- Condition
- Metastatic Breast Cancer, Lobular Breast Carcinoma
- Tested
- Blood Specimen
- Sponsor
- University of California, San Francisco
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 6
- Minimum age: 18 years
- Study condition: Metastatic Breast Cancer, Lobular Breast Carcinoma
- Histologically confirmed invasive lobular carcinoma. Mixed lobular/ductal cancer is allowed.
- Age \>=18 years
- Any receptor subtype.
- Ability to understand a written informed consent document, and the willingness to sign it.
Exclusion 3
- Stage I-III breast cancer.
- Lack of lobular histology on tumor biopsy.
- Other active cancer (prior treated cancer with no current evidence of disease is allowed).
Where
4 sites, 4 recruiting
MD Anderson Cancer Center
Houston, Texas, United States
Abramson Cancer Center
Philadelphia, Pennsylvania, United States
University of California, San Diego
San Diego, California, United States
University of California, San Francisco
San Francisco, California, United States
Contact
-
Venezia Garza
415-353-8732 venezia.garza@ucsf.edu
Potential match only. Final eligibility is determined by the study team.